{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:16:22Z","timestamp":1790226982007,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007192","name":"Netherlands National Institute for Public Health and the Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI088791"],"award-info":[{"award-number":["U19 AI088791"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIAID U19 U19 AI066345"],"award-info":[{"award-number":["NIAID U19 U19 AI066345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA016017"],"award-info":[{"award-number":["R01 DA016017"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ATAHC","award":["NIDA RO1 DA 15999-01"],"award-info":[{"award-number":["NIDA RO1 DA 15999-01"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["222887"],"award-info":[{"award-number":["222887"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1016351"],"award-info":[{"award-number":["1016351"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["510488"],"award-info":[{"award-number":["510488"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["1053206"],"award-info":[{"award-number":["1053206"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["331312"],"award-info":[{"award-number":["331312"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["545891"],"award-info":[{"award-number":["545891"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"UNSW","doi-asserted-by":"publisher","award":["630483"],"award-info":[{"award-number":["630483"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Victorian Operational Infrastructure Support Programme"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-103138"],"award-info":[{"award-number":["MOP-103138"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP- MOP-133680"],"award-info":[{"award-number":["MOP- MOP-133680"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.meegid.2017.01.006","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T05:48:22Z","timestamp":1483681702000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-9177","authenticated-orcid":false,"given":"Chaturaka","family":"Rodrigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preston","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auda A.","family":"Eltahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Osburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janke","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa H.","family":"Shoukry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena A.","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2017.01.006_bb0005","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1128\/JVI.02070-15","article-title":"Monoclonal antibodies directed toward the hepatitis C virus glycoprotein E2 detect antigenic differences modulated by the N-terminal hypervariable region 1 (HVR1), HVR2, and Intergenotypic variable region","volume":"89","author":"Alhammad","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-0556-9-7","article-title":"In-vitro model systems to study hepatitis C virus","volume":"9","author":"Ashfaq","year":"2011","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.meegid.2017.01.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100325","article-title":"High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody","volume":"9","author":"Babcock","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.01.006_bb0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI78794","article-title":"Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance","volume":"125","author":"Bailey","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2017.01.006_bb0025","doi-asserted-by":"crossref","first-page":"E1156","DOI":"10.1073\/pnas.1103764108","article-title":"Role of donor genital tract HIV-1 diversity in the transmission bottleneck","volume":"108","author":"Boeras","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2017.01.006_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.meegid.2017.01.006_bb0035","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002243","article-title":"Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection","volume":"7","author":"Bull","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2017.01.006_bb0045","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/ajt.12083","article-title":"Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study","volume":"13","author":"Chung","year":"2013","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transplant Surg."},{"key":"10.1016\/j.meegid.2017.01.006_bb0050","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1146\/annurev-immunol-032712-095916","article-title":"Broadly neutralizing antiviral antibodies","volume":"31","author":"Corti","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0055","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1128\/JVI.02153-09","article-title":"Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies","volume":"84","author":"Dhillon","year":"2010","journal-title":"J. Virol."},{"issue":"223\u2013233","key":"10.1016\/j.meegid.2017.01.006_bb0060","article-title":"Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies","volume":"143","author":"Fofana","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0065","doi-asserted-by":"crossref","first-page":"19450","DOI":"10.1073\/pnas.0809879105","article-title":"In vitro selection of a neutralization-resistant hepatitis C virus escape mutant","volume":"105","author":"Gal-Tanamy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2017.01.006_bb0070","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2017.01.006_bb0075","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0080","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/ije\/dys167","article-title":"Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study","volume":"42","author":"Grebely","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.26639","article-title":"The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection","volume":"59","author":"Grebely","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0090","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157353","article-title":"Repeated vaccination of cows with HIV Env gp140 during subsequent pregnancies elicits and sustains an enduring strong Env-binding and Neutralising antibody response","volume":"11","author":"Heydarchi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.01.006_bb0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2190345","article-title":"IUPAC-IUB joint commission on biochemical nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983","volume":"219","author":"IUPAC","year":"1984","journal-title":"Biochem. J."},{"key":"10.1016\/j.meegid.2017.01.006_bb0105","doi-asserted-by":"crossref","first-page":"16269","DOI":"10.1073\/pnas.0705522104","article-title":"Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus","volume":"104","author":"Johansson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2017.01.006_bb0110","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/JVI.02554-10","article-title":"Reproduction in vitro of a quasispecies from a hepatitis C virus-infected patient and determination of factors that influence selection of a dominant species","volume":"85","author":"Kawaguchi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein","volume":"87","author":"Keck","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004297","article-title":"Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423","volume":"10","author":"Keck","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.meegid.2017.01.006_bb0125","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.1128\/JVI.00252-08","article-title":"A point mutation leading to hepatitis C virus escape from neutralization by a monoclonal antibody to a conserved conformational epitope","volume":"82","author":"Keck","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0130","doi-asserted-by":"crossref","first-page":"10451","DOI":"10.1128\/JVI.05259-11","article-title":"Mapping a region of hepatitis C virus E2 that is responsible for escape from neutralizing antibodies and a core CD81-binding region that does not tolerate neutralization escape mutations","volume":"85","author":"Keck","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0135","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/JVI.01710-06","article-title":"Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions","volume":"81","author":"Keck","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2017.01.006_bb0145","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.meegid.2017.01.006_bb0150","doi-asserted-by":"crossref","first-page":"D512","DOI":"10.1093\/nar\/gkm962","article-title":"The hepatitis C sequence database in Los Alamos","volume":"36","author":"Kuiken","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2017.01.006_bb0155","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.22549","article-title":"Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naive patients","volume":"48","author":"Kuntzen","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0160","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2017.01.006_bb0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.meegid.2017.01.006_bb0170","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.meegid.2017.01.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008254","article-title":"Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes","volume":"4","author":"Mancini","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.01.006_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jcv.2014.12.014","article-title":"Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis","volume":"64","author":"May","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0185","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0195","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/hep.27013","article-title":"Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses","volume":"59","author":"Osburn","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0200","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0205","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/vir.0.83386-0","article-title":"Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein","volume":"89","author":"Owsianka","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0210","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.jmb.2013.02.025","article-title":"Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies","volume":"425","author":"Pantua","year":"2013","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0215","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1128\/JVI.01986-07","article-title":"Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein","volume":"82","author":"Perotti","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0220","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.23885","article-title":"Frequent multiple hepatitis C virus infections among injection drug users in a prison setting","volume":"52","author":"Pham","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.meegid.2017.01.006_bb0225","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/hep.28705","article-title":"Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity","volume":"64","author":"Prentoe","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/jvh.12616","article-title":"Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 study","volume":"24","author":"Rodrigo","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.meegid.2017.01.006_bb0235","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1743-422X-5-46","article-title":"Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding","volume":"5","author":"Rothwangl","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.meegid.2017.01.006_bb0240","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C virus reinfection and spontaneous clearance of reinfection-the InC3 study","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2017.01.006_bb0245","doi-asserted-by":"crossref","first-page":"450963","DOI":"10.1155\/2013\/450963","article-title":"Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies","volume":"2013","author":"Sautto","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0250","first-page":"387","article-title":"New therapeutic options for HCV infection in the monoclonal antibody era","volume":"35","author":"Sautto","year":"2012","journal-title":"New Microbiol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055874","article-title":"Isolation of human monoclonal antibodies to the envelope e2 protein of hepatitis C virus and their characterization","volume":"8","author":"Shimizu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2017.01.006_bb0260","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0265","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.26430","article-title":"An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission","volume":"58","author":"Tarr","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0270","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1099\/vir.0.83065-0","article-title":"Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33","volume":"88","author":"Tarr","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0275","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/hep.21088","article-title":"Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33","volume":"43","author":"Tarr","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2017.01.006_bb0280","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3390\/v3112127","article-title":"Neutralizing antibody response to hepatitis C virus","volume":"3","author":"Wang","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.meegid.2017.01.006_bb0285","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JVI.02837-15","article-title":"A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies","volume":"90","author":"Wasilewski","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2017.01.006_bb0290","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12864-015-2358-7","article-title":"Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment","volume":"17","author":"Wu","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.meegid.2017.01.006_bb0295","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"Zeisel","year":"2011","journal-title":"J. Hepatol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134817300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T23:49:48Z","timestamp":1657756188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134817300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":59,"alternative-id":["S1567134817300059"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2017.01.006","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2017.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}